Nebius (NL) shares (NBIS)

Key Updates

Nebius shares plunged -11.10% to $91.19 since the February 25 report, breaking below the critical $100 psychological support level and erasing all gains from the post-earnings rally. The decline accelerates the broader correction pattern, with shares now down -13.05% in one day and -35.8% from the December 2025 high of $142. The single new development—a comprehensive market analysis dated February 23—confirms the stock consolidated around $99.45 before this latest selloff, attributing weakness to market-wide rotation into infrastructure value plays and investor concerns over the aggressive $18 billion capex plan for 2026-2027. YTD performance remains positive at +8.94%, but momentum has reversed sharply from the +18.50% surge documented in the February 20 report.

Current Trend

Nebius exhibits a clear downtrend across all timeframes except the 6-month (+30.09%) and YTD (+8.94%) windows. The stock declined -13.05% in one day, -6.87% over five days, and -9.20% over one month, establishing a pattern of accelerating weakness. The current price of $91.19 sits approximately 36% below the analyst consensus target of $143.67 and 39.7% below the late 2025 high of $142. Critical support at $100—tested successfully in the February 20-25 period—has now failed decisively. The next technical support appears near the $85-86 range where the stock traded in early February following positive AI advancement announcements. The YTD gain of +8.94% provides a buffer above year-end levels, but the recent velocity of decline suggests further downside risk if broader market rotation continues.

Investment Thesis

The investment case for Nebius centers on the company's positioning as a specialized AI infrastructure provider competing in the high-growth GPU-as-a-Service market. The thesis rests on four pillars: (1) successful execution of major multi-billion dollar contracts with Microsoft and Meta, (2) ability to scale capacity amid surging AI workload demand, (3) competitive valuation at under 2.8x forward P/S versus neocloud peers, and (4) diversified revenue streams through Avride, TripleTen, and equity stakes in ClickHouse and Toloka. The company demonstrated 355.14% revenue growth over three months as of September 30, 2025, with Q4 revenue reaching $117.5M. The recent Israel AI supercomputer mandate adds strategic validation. However, the thesis faces significant execution risk from the unprecedented $18 billion capex commitment for 2026-2027, which raises questions about capital efficiency, dilution risk, and the company's ability to generate adequate returns on this massive infrastructure investment.

Thesis Status

The investment thesis has materially weakened since the February 25 report. While fundamental developments remain constructive—including the Israel supercomputer mandate, strong Q4 performance, and institutional ownership increases in Q1 2026—the market's focus has shifted decisively to execution risk and capital allocation concerns. The $18 billion capex plan, previously viewed as growth-enabling, now appears to be the primary driver of the 36% discount to analyst price targets. The breakdown below $100 support suggests investors are repricing the stock for higher risk premiums and longer payback periods on infrastructure investments. Institutional rotation from Mag 7 stocks into infrastructure specialists like Nebius, documented in the February 23 analysis, has not prevented the selloff, indicating broader sector-wide pressure. The thesis remains intact for long-term holders with conviction in AI infrastructure demand, but near-term price action suggests the market requires tangible proof of capital efficiency before re-rating the stock toward analyst targets.

Key Drivers

The primary catalyst driving current weakness is market concern over Nebius's massive $18 billion capital expenditure plan for 2026-2027, which has triggered a reassessment of risk-reward dynamics despite strong operational performance. Broader market rotation into infrastructure value plays has pressured high-growth AI infrastructure stocks. Positive offsetting factors include institutional ownership increases in Q1 2026 as hedge funds pivot from Mag 7 stocks and the Israel Innovation Authority's selection of Nebius to build and operate the national AI supercomputer infrastructure. The company's 355.14% revenue growth and Buy consensus rating with $143.67 average price target provide fundamental support. Management's ability to provide clarity on facility updates, capacity ramp execution, and return on capital metrics will determine whether the stock can stabilize and reverse the current downtrend.

Technical Analysis

Nebius has entered a technical breakdown phase, breaching the $100 psychological support that held during the February 20-25 period. The current price of $91.19 represents a -35.8% decline from the $142 December 2025 high and sits at the lower end of the recent trading range. Volume patterns suggest accelerating distribution, with the -13.05% single-day decline indicating capitulation selling. Key resistance now sits at $100 (former support), with intermediate resistance at $105-110. Immediate support appears at $85-86, where the stock found buyers in early February during the AI advancement rally. A break below $85 would target the $73 level mentioned in volatile trading patterns. The stock's relative strength has deteriorated sharply, with the 1-month, 5-day, and 1-day timeframes all showing negative momentum. The 6-month chart (+30.09%) reveals a clear peak-and-decline pattern, while YTD performance (+8.94%) suggests the $84-85 range represents year-end pricing. Mean reversion traders may view the 36% discount to analyst targets as attractive, but momentum indicators suggest waiting for stabilization signals before establishing long positions.

Bull Case

• Multi-billion dollar contracts with Microsoft and Meta provide revenue visibility and validate Nebius's competitive positioning in the GPU-as-a-Service market, with institutional ownership increasing in Q1 2026 as hedge funds rotate into infrastructure specialists.
• Exceptional 355.14% revenue growth over three months and analyst consensus Buy rating with $143.67 average price target implies 54.68% upside potential from current levels, suggesting the market has overreacted to near-term execution concerns.
• Israel AI supercomputer mandate positions Nebius at the center of a state-backed national AI ecosystem, providing strategic validation, recurring revenue streams, and potential template for additional sovereign AI infrastructure contracts globally.
• Valuation at under 2.8x forward P/S trades below most neocloud peers despite strong capacity ramp, creating a compelling risk-reward setup for investors willing to look through near-term volatility toward 2027 revenue potential.
• 12-month stock surge of over 210% and institutional rotation from Mag 7 into infrastructure specialists demonstrates sustained investor conviction in the AI infrastructure thesis, with current weakness representing a consolidation phase rather than fundamental deterioration.

Bear Case

• $18 billion capital expenditure plan for 2026-2027 raises critical questions about capital efficiency, dilution risk, and return on investment, with the market-wide rotation into infrastructure value plays reflecting skepticism about aggressive growth capex in the current environment.
• 35.8% decline from $142 late 2025 high to current $91.19 demonstrates severe momentum deterioration, with the breakdown below $100 psychological support suggesting further technical damage and potential for additional capitulation toward $73-85 support zone.
• Anticipated EPS of -$0.54 for Q4 2025 highlights continued unprofitability, creating execution risk as the company must simultaneously invest $18 billion in infrastructure while proving it can achieve positive unit economics and sustainable cash flow generation.
• Volatile price behavior with fluctuations between highs over $100 and lows near $73 indicates unstable investor sentiment and lack of conviction, with recent $117.5M quarterly revenue appearing insufficient to support current $24.7 billion market capitalization without significant growth acceleration.
• Current trading price of $91.19 represents approximately 40% discount to analyst consensus target of $151.50, suggesting either analysts have not adequately incorporated execution risk or the market is pricing in material probability of capital plan delays, competitive pressure, or demand shortfalls.